Performance and survival of transvenous defibrillation leads: need for a European data registry
Key result
Reported ICD lead survival varies significantly across studies, ranging from 91-99% at 2 years to 60-72% at 8 years, highlighting the need for a comprehensive registry to monitor lead performance.
Population
Patients with implantable cardioverter defibrillators (ICDs) and transvenous defibrillation leads
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Variable ICD lead survival data warrant caution in device counseling; leaves open true long-term failure rates pending a unified registry.
Structured PICO
P
Population
Patients with implantable cardioverter defibrillators (ICDs) and transvenous defibrillation leads
E
Exposure
Implantable cardioverter defibrillator (ICD) transvenous leads
O
Outcome
ICD lead performance, survival, and incidence of lead malfunctionsafety
Due to highly variable reported survival rates of ICD leads and small existing cohorts, there is a critical need for a comprehensive Europe-wide registry to accurately monitor long-term lead performance and safety.
Limitations
- Published long-term results from national or multicentre registries encompass relatively small patient cohorts.
- The true incidence of lead malfunction cannot be defined based on current data.
- Inadequate reporting of ICD lead performance
- Lack of a European or worldwide registry
- Published long-term results encompass relatively small patient cohorts
Cite This Study
Goette et al. (2008) conducted a review in Implantable cardioverter defibrillator (ICD) lead performance. Implantable cardioverter defibrillator (ICD) leads was evaluated on ICD lead survival. Reported ICD lead survival varies significantly across studies, ranging from 91-99% at 2 years to 60-72% at 8 years, highlighting the need for a comprehensive registry to monitor lead performance.